Clinical Trials Browser

Recruiting × NIH × enzalutamide × Clear all

NCT06096870 2026-03-19

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Phase 2 Recruiting

Prostatic Neoplasms